| All Reports (Showing 1 to 10 of 34) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 9-Feb-10 | New Constructs, LLC | N/A | VRTX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | | | View Abstract |
| 9-Feb-10 | EconomicInvestor | N/A | "The Economy Matters" Report for VRTX: the economy's impact on VRTX's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | | | View Abstract |
| 8-Feb-10 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 100 | $169 | | | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 98 | $169 | | | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: VERTEX PHARMACEU -- VRTX | 1 | $4 | | | View Abstract |
| 5-Feb-10 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VERTEX PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ABII , CELG , ENZN , KNDL , LIFE , MATK , ONTY , VRTX -- DRUGS | 3 | $4 | | | View Abstract |
| 3-Feb-10 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Vertex Pharmaceuticals Inc | 43 | $65 | | | View Abstract |
| 1-Feb-10 | Roth Capital Partners, Inc. | Edward Nash | Achillion Corporate Update: Achillion Growing On All Fronts | 6 | $25 | | | View Abstract |